|
HOUSE OF REPRESENTATIVES |
H.B. NO. |
1359 |
|
THIRTY-FIRST LEGISLATURE, 2021 |
|
|
|
STATE OF HAWAII |
|
|
|
|
|
|
|
|
||
|
|
||
A BILL FOR AN ACT
RElating to higher education.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:
SECTION 1. The legislature finds that with nearly thirty thousand registered medical cannabis patients in Hawaii, there is an unmet need for expertise in the field of cannabinoid medicine to facilitate the exchange of educational and research information related to the state-authorized use of cannabis for medical purposes in Hawaii.
The legislature also finds that the appropriate place for this expertise would be within the school of medicine of the university of Hawaii.
The purpose of this Act is to create a cannabinoid medicine program within the university of Hawaii to be administered by the school of medicine of the university of Hawaii.
SECTION 2. Chapter 304A, Hawaii Revised Statutes, is amended by adding a new section to subpart M of part IV to be appropriately designated and to read as follows:
"§304A- Cannabinoid
medicine program; established. (a)
There is established within the university of Hawaii the cannabinoid medicine
program to be administered by the school of medicine of the university of Hawaii.
(b) The program shall include at least one
non-paid associate professor position that shall be filled with a medical or
osteopathic doctor who is a certified cannabinoid medicine specialist. All positions
of the program shall be appointed by the dean of the school of medicine of the university
of Hawaii.
(c) The program shall pursue education and
research related to the state-authorized use of cannabis for medical purposes
in Hawaii in order to uphold patient safety and promote the development of
Hawaii as an international center for medical cannabis research and treatment.
(d) The activities of the program shall include:
(1) Coordinating
with the medical cannabis testing and research programs established pursuant to
section 304A-1865 to provide medical and scientific expertise on the various
projects being undertaken by the programs;
(2) Participating
in the development of cannabinoid medicine education for the medical school of the
university of Hawaii problem-based learning curriculum;
(3) Providing
continuing medical education on the medical use of cannabis in Hawaii to the
medical community;
(4) Working with
the department of health to establish standardized analytical testing methods;
and
(5) Working with
the office of medical cannabis control and regulation established pursuant to section
329D‑2.5 to ensure regulatory compliance by patients, laboratories, and
dispensaries."
SECTION 3. New statutory material is underscored.
SECTION 4. This Act shall take effect upon its approval.
|
INTRODUCED BY: |
_____________________________ |
|
|
|
Report Title:
UH; Cannabinoid Medicine Program
Description:
Establishes the cannabinoid medicine program within the school of medicine of the university of Hawaii.
The summary description
of legislation appearing on this page is for informational purposes only and is
not legislation or evidence of legislative intent.